Deutsch English Français

Contact

EP1228080

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1228080

EP1228080 - COMPOSITIONS AND METHODS FOR DOUBLE-TARGETING VIRUS INFECTIONS AND TARGETING CANCER CELLS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 25.05.2012 Database last updated on 15.07.2024
Most recent event Tooltip	25.05.2012	Application deemed to be withdrawn	published on 27.06.2012 [2012/26]
Applicant(s)	For all designated states WAKE FOREST UNIVERSITY Medical Center Boulevard Winston-Salem, NC 27157-1023 / US
	For all designated states THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL Office of Technology Development, Campus Box 4105, 308 Bynum Hall Chapel Hill, NC 27599-4105 / US
	[N/P]
Former [2002/32]	For all designated states WAKE FOREST UNIVERSITY Medical Center Boulevard Winston-Salem, NC 27157-1023 / US
	For all designated states The University of North Carolina at Chapel Hill Office of Technology Development, Campus Box 4105, 308 Bynum Hall Chapel Hill, NC 27599-4105 / US
Inventor(s)	01 / KUCERA, Louis, S. 4860 Ellen Avenue Pfafftown, NC 27040 / US
	02 / FLEMING, Robert, A. 107 Smiths Knoll Court Cary, NC 27513 / US
	03 / ISHAQ, Khalid, S. 105 Hunter Hill Place Chapel Hill, NC 27514 / US
	04 / KUCERA, Gregory, L. 705 Manly Street Winston-Salem, NC 27101 / US
	05 / MORRIS-NATSCHKE, Susan L. 1225 Martha's Chapel Road, Rt. 3, Box 184P Apex, NC 27502 / US
	[2002/40]
Former [2002/32]	01 / KUCERA, Louis, S. 4860 Ellen Avenue Pfafftown, NC 27040 / US
	02 / FLEMING, Ronald, A. 1005 Greenly Drive Pfafftown, NC 27040 / US
	03 / ISHAQ, Khalid, S. 105 Hunter Hill Place Chapel Hill, NC 27514 / US
	04 / KUCERA, Gregory, L. 705 Manly Street Winston-Salem, NC 27101 / US
	05 / MORRIS-NATSCHKE, Susan L. 1225 Martha's Chapel Road, Rt. 3, Box 184P Apex, NC 27502 / US
Representative(s)	Graf von Stosch, Andreas Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE
	[N/P]
Former [2010/07]	Graf von Stosch, Andreas Graf von Stosch Patentanwaltsgesellschaft mbH Prinzregentenstrasse 22 80538 München / DE
Former [2002/32]	Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät Maximilianstrasse 58 80538 München / DE
Application number, filing date	00989666.3	20.10.2000
	[2002/32]
	WO2000US41352
Priority number, date	US19990162290P	28.10.1999 Original published format: US 162290 P
	[2002/32]
Filing language	EN
Procedural language	EN
Publication	Type:	A2 Application without search report
	No.:	WO0134614
	Date:	17.05.2001
	Language:	EN
	[2001/20]
	Type:	A2 Application without search report
	No.:	EP1228080
	Date:	07.08.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 17.05.2001 takes the place of the publication of the European patent application.
	[2002/32]
Search report(s)	International search report - published on:	EP	27.12.2001
Classification	IPC:	C07H19/06, C07H19/16, C07F9/10, A61K31/7052, A61K31/685, A61P31/12, A61P35/00	[2002/32]
	CPC:	C07H19/06 (EP,US); A61K31/66 (EP,US); A61K31/675 (EP,US); A61P1/16 (EP); A61P13/12 (EP); A61P25/00 (EP); (+) A61P31/12 (EP); A61P31/18 (EP); A61P31/22 (EP); A61P35/00 (EP); A61P35/02 (EP); A61P9/00 (EP); C07F9/10 (EP,US); C07H19/10 (EP,US); C07H19/16 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/32]
Extension states	AL	28.05.2002
	LT	28.05.2002
	LV	28.05.2002
	MK	28.05.2002
	RO	28.05.2002
	SI	28.05.2002
Title	German:	ZUSAMMENSETZUNGEN UND METHODEN ZUR DOPPELTARGETING VON VIRUSINFEKTIONEN UND TARGETING KREBSZELLEN	[2002/32]
	English:	COMPOSITIONS AND METHODS FOR DOUBLE-TARGETING VIRUS INFECTIONS AND TARGETING CANCER CELLS	[2002/32]
	French:	COMPOSITIONS ET METHODES POUR DOUBLE CIBLAGE D'INFECTIONS VIRALES ET CIBLAGE DE CELLULES CANCEREUSES	[2002/32]
Entry into regional phase	28.05.2002	National basic fee paid
	28.05.2002	Designation fee(s) paid
	28.05.2002	Examination fee paid
Examination procedure	08.05.2001	Request for preliminary examination filed International Preliminary Examining Authority: US
	28.05.2002	Amendment by applicant (claims and/or description)
	28.05.2002	Examination requested [2002/32]
	11.03.2009	Despatch of a communication from the examining division (Time limit: M04)
	21.07.2009	Reply to a communication from the examining division
	15.02.2011	Despatch of a communication from the examining division (Time limit: M04)
	14.06.2011	Reply to a communication from the examining division
	19.08.2011	Communication of intention to grant the patent
	30.12.2011	Application deemed to be withdrawn, date of legal effect [2012/26]
	06.02.2012	Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2012/26]
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 11.03.2009
Fees paid	Renewal fee
	28.05.2002	Renewal fee patent year 03
	30.10.2003	Renewal fee patent year 04
	27.10.2004	Renewal fee patent year 05
	12.10.2005	Renewal fee patent year 06
	26.10.2006	Renewal fee patent year 07
	12.10.2007	Renewal fee patent year 08
	31.10.2008	Renewal fee patent year 09
	26.10.2009	Renewal fee patent year 10
	25.10.2010	Renewal fee patent year 11
	Penalty fee
	Additional fee for renewal fee
	31.10.2011	12 M06 Not yet paid
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited in	International search	[A]WO8803146 (FUJI CHEM IND CO LTD [JP]) [A] 1,2,20,23 * abstract *;
		[A]WO9119726 (UNIV WAKE FOREST [US], et al) [A] 1,23 * the whole document *;
		[A]WO9606620 (UNIV WAKE FOREST [US], et al) [A] 1,23 * claims 59-74 *;
		[AD] - PIANTADOSI C ET AL, "SYNTHESIS AND EVALUATION OF NOVEL ETHER LIPID NUCLEOSIDE CONJUGATES FOR ANTI-HIV-1 ACTIVITY", JOURNAL OF MEDICINAL CHEMISTRY,US,AMERICAN CHEMICAL SOCIETY. WASHINGTON, (1991), vol. 34, no. 4, ISSN 0022-2623, pages 1408 - 1414, XP002000878 [AD] 1,23 * the whole document * DOI: http://dx.doi.org/10.1021/jm00108a025
		[AD] - HONG C I ET AL, "FORMULATION, STABILITY, AND ANTITUMOR ACTIVITY OF 1-BETA-D-ARABINOFURANOSYLCYTOSINE CONJUGATE OF THIOETHER PHOSPHOLIPID", CANCER RESEARCH,US,AMERICAN ASSOCIATION FOR CANCER RESEARCH, BALTIMORE, MD, (19900715), vol. 50, no. 14, ISSN 0008-5472, pages 4401 - 4406, XP000571731 [AD] 1,23 * abstract figure 1 *

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p